ATP1A2
ATP1A2 (ATPase Na+/K+ transporting subunit alpha 2, also known as FHM2 and MHP2) encodes the alpha-2 catalytic subunit of the Na+/K+-ATPase. It hydrolyses ATP to export sodium and import potassium across the plasma membrane, maintaining the ion gradients that cells depend on. Browse Assay Genie's current range of ATP1A2 research reagents below, or read on for the biology behind the target.
ATP1A2 is the catalytic subunit of the Na+/K+-ATPase, an integral membrane enzyme that uses the energy of ATP hydrolysis to exchange ions across the plasma membrane. In each cycle it exports 3 Na+ and imports 2 K+. ATP-driven conformational changes allow alternating binding and release of Na+ and K+, and this activity maintains the Na+ and K+ gradients required for membrane potential and cellular function.
The ATP1A2 gene encodes an alpha 2 subunit. The catalytic subunit of Na+/K+-ATPase is encoded by multiple genes, and the HGNC places ATP1A2 in the group of ATPase Na+/K+ transporting subunits. The enzyme is composed of a large catalytic alpha subunit and a smaller glycoprotein beta subunit. The protein belongs to the P-type cation transport ATPase family (type IIC subfamily). The electrochemical gradients it sustains are essential for osmoregulation, for sodium-coupled transport of organic and inorganic molecules, and for the electrical excitability of nerve and muscle. The mouse and rat orthologs are both named Atp1a2.
Mutations in ATP1A2 cause familial basilar or hemiplegic migraines, and a rare syndrome called alternating hemiplegia of childhood. This disease link explains the earlier gene name "migraine, hemiplegic 2" and the aliases FHM2 and MHP2. Researchers studying the ATP1A2 protein therefore work across ion transport biology, neurological disease and membrane physiology.
The Na+/K+-ATPase sets the Na+ and K+ gradients across the plasma membrane, so ATP1A2 is a focus for studying active ion exchange.
Mutations in ATP1A2 cause familial basilar or hemiplegic migraines, making the gene central to research on inherited migraine.
ATP1A2 mutations are associated with alternating hemiplegia of childhood, a rare syndrome studied alongside other Na+/K+-ATPase alpha subunit genes.
Na+ and K+ gradients underpin electrical excitability of nerve and muscle, a context in which the alpha 2 subunit is investigated.
ATP1A2 encodes the alpha 2 catalytic subunit of the Na+/K+-ATPase. It hydrolyses ATP to export 3 Na+ and import 2 K+ per cycle across the plasma membrane, maintaining the gradients needed for membrane potential and cellular function.
ATP1A2 is also known as FHM2 and MHP2. Earlier HGNC names include "migraine, hemiplegic 2" and "ATPase, Na+/K+ transporting, alpha 2 polypeptide". UniProt calls the protein sodium/potassium-transporting ATPase subunit alpha-2, and it carries EC number 7.2.2.13.
Mutations in the ATP1A2 gene result in familial basilar or hemiplegic migraines and in alternating hemiplegia of childhood. Orthologs exist in mouse and rat, both named Atp1a2; check the datasheet of any product for its validated reactivity.
Other Na+/K+-ATPase subunits, P-type ATPases and related ion pump targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P50993; product specifications from Assay Genie datasheets.